User menu

A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors

Bibliographic reference Shahbazi, Mohammad-Ali ; Shrestha, Neha ; Mäkilä, Ermei ; Araújo, Francisca ; Correia, Alexandra ; et. al. A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors. In: Nano Research, Vol. 8, no.5, p. 1505-1521 (2014)
Permanent URL http://hdl.handle.net/2078/181192
  1. Nowak Anna K., Lake Richard A., Robinson Bruce W.S., Combined chemoimmunotherapy of solid tumours: Improving vaccines?, 10.1016/j.addr.2006.04.002
  2. Lee In-Hyun, An Sukyung, Yu Mi Kyung, Kwon Ho-Keun, Im Sin-Hyeog, Jon Sangyong, Targeted chemoimmunotherapy using drug-loaded aptamer–dendrimer bioconjugates, 10.1016/j.jconrel.2011.05.025
  3. Molavi Ommoleila, Xiong Xiao-Bing, Douglas Donna, Kneteman Norm, Nagata Satoshi, Pastan Ira, Chu Quincy, Lavasanifar Afsaneh, Lai Raymond, Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma, 10.1016/j.biomaterials.2013.07.068
  4. Maeda Hiroshi, Matsumura Yasuhiro, EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy, 10.1016/j.addr.2010.05.001
  5. Byrne James D., Betancourt Tania, Brannon-Peppas Lisa, Active targeting schemes for nanoparticle systems in cancer therapeutics, 10.1016/j.addr.2008.08.005
  6. Chattopadhyay, N.; Fonge, H.; Cai, Z.; Scollard, D.; Lechtman, E.; Done, S. J.; Pignol, J. P.; Reilly, R. M. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol. Pharmaceutics 2012, 9, 2168–2179.
  7. Lu Ying-mei, Huang Ji-yun, Wang Huan, Lou Xue-fang, Liao Mei-hua, Hong Ling-juan, Tao Rong-rong, Ahmed Muhammad M., Shan Chun-lei, Wang Xiao-liang, Fukunaga Kohji, Du Yong-zhong, Han Feng, Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles, 10.1016/j.biomaterials.2013.09.093
  8. Fiandra Luisa, Mazzucchelli Serena, De Palma Clara, Colombo Miriam, Allevi Raffaele, Sommaruga Silvia, Clementi Emilio, Bellini Michela, Prosperi Davide, Corsi Fabio, Assessing the In Vivo Targeting Efficiency of Multifunctional Nanoconstructs Bearing Antibody-Derived Ligands, 10.1021/nn4018922
  9. Weiner Louis M., Surana Rishi, Wang Shangzi, Monoclonal antibodies: versatile platforms for cancer immunotherapy, 10.1038/nri2744
  10. Portnoy Emma, Lecht Shimon, Lazarovici Philip, Danino Dganit, Magdassi Shlomo, Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging, 10.1016/j.nano.2011.01.001
  11. Berlin Jacob M., Pham Tam T., Sano Daisuke, Mohamedali Khalid A., Marcano Daniela C., Myers Jeffrey N., Tour James M., Noncovalent Functionalization of Carbon Nanovectors with an Antibody Enables Targeted Drug Delivery, 10.1021/nn2021293
  12. Gu Luo, Ruff Laura E., Qin Zhengtao, Corr Maripat, Hedrick Stephen M., Sailor Michael J., Multivalent Porous Silicon Nanoparticles Enhance the Immune Activation Potency of Agonistic CD40 Antibody, 10.1002/adma.201200776
  13. Illum, L.; Jones, P. D.; Baldwin, R. W.; Davis, S. S. Tissue distribution of poly(hexyl-2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts. J. Pharmacol. Exp. Ther. 1984, 230, 733–736.
  14. Chinol M, Casalini P, Maggiolo M, Canevari S, Omodeo ES, Caliceti P, Veronese FM, Cremonesi M, Chiolerio F, Nardone E, Siccardi AG, Paganelli G, Biochemical modifications of avidin improve pharmacokinetics and biodistribution and reduce immunogenicity, 10.1038/bjc.1998.463
  15. Scott Diane, Nitecki Danute E., Kindler Hedy, Goodman Joel W., Immunogenicity of biotinylated Hapten-Avidin complexes, 10.1016/0161-5890(84)90115-9
  16. Zhao Jing, Mi Yu, Liu Yutao, Feng Si-Shen, Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend, 10.1016/j.biomaterials.2011.11.051
  17. Liu Yutao, Li Kai, Liu Bin, Feng Si-Shen, A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery, 10.1016/j.biomaterials.2010.08.053
  18. Venturelli Enrica, Fabbro Chiara, Chaloin Olivier, Ménard-Moyon Cécilia, Smulski Cristian R., Da Ros Tatiana, Kostarelos Kostas, Prato Maurizio, Bianco Alberto, Antibody Covalent Immobilization on Carbon Nanotubes and Assessment of Antigen Binding, 10.1002/smll.201100137
  19. Firer Michael A, Gellerman Gary, Targeted drug delivery for cancer therapy: the other side of antibodies, 10.1186/1756-8722-5-70
  20. Mitra, M.; Misra, R.; Harilal, A.; Sahoo, S. K.; Krishnakumar, S. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mol. Vis. 2011, 17, 2724–2737.
  21. Winter Manon J., Nagtegaal Iris D., van Krieken J. Han J.M., Litvinov Sergey V., The Epithelial Cell Adhesion Molecule (Ep-CAM) as a Morphoregulatory Molecule Is a Tool in Surgical Pathology, 10.1016/s0002-9440(10)63570-5
  22. Martowicz Agnieszka, Spizzo Gilbert, Gastl Guenther, Untergasser Gerold, Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines, 10.1186/1471-2407-12-501
  23. Santos Hélder A., Bimbo Luis M., Herranz Barbara, Shahbazi Mohammad-Ali, Hirvonen Jouni, Salonen Jarno, Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside, 10.1557/jmr.2012.271
  24. Shahbazi Mohammad-Ali, Almeida Patrick V., Mäkilä Ermei, Correia Alexandra, Ferreira Mónica P. A., Kaasalainen Martti, Salonen Jarno, Hirvonen Jouni, Santos Hélder A., Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization, 10.1002/marc.201300868
  25. Shahbazi Mohammad-Ali, Hamidi Mehrdad, Mäkilä Ermei M., Zhang Hongbo, Almeida Patrick V., Kaasalainen Martti, Salonen Jarno J., Hirvonen Jouni T., Santos Hélder A., The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility, 10.1016/j.biomaterials.2013.06.052
  26. Shahbazi Mohammad-Ali, Herranz Barbara, Santos Hélder A., Nanostructured porous Si-based nanoparticles for targeted drug delivery, 10.4161/biom.22347
  27. Barnes Timothy J, Jarvis Karyn L, Prestidge Clive A, Recent advances in porous silicon technology for drug delivery, 10.4155/tde.13.52
  28. Zhang Mingzhen, Xu Rong, Xia Xiaojun, Yang Yong, Gu Jianhua, Qin Guoting, Liu Xuewu, Ferrari Mauro, Shen Haifa, Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells, 10.1016/j.biomaterials.2013.09.033
  29. Tabasi Ozra, Falamaki Cavus, Khalaj Zahra, Functionalized mesoporous silicon for targeted-drug-delivery, 10.1016/j.colsurfb.2012.04.018
  30. Ferris Daniel P., Lu Jie, Gothard Chris, Yanes Rolando, Thomas Courtney R., Olsen John-Carl, Stoddart J. Fraser, Tamanoi Fuyuhiko, Zink Jeffrey I., Synthesis of Biomolecule-Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells, 10.1002/smll.201002300
  31. Xu Rong, Huang Yi, Mai Junhua, Zhang Guodong, Guo Xiaojing, Xia Xiaojun, Koay Eugene J., Qin Guoting, Erm Donald R., Li Qingpo, Liu Xuewu, Ferrari Mauro, Shen Haifa, Multistage Vectored siRNA Targeting Ataxia-Telangiectasia Mutated for Breast Cancer Therapy, 10.1002/smll.201201510
  32. Rytkönen Jussi, Arukuusk Piret, Xu Wujun, Kurrikoff Kaido, Langel Ülo, Lehto Vesa-Pekka, Närvänen Ale, Porous Silicon–Cell Penetrating Peptide Hybrid Nanocarrier for Intracellular Delivery of Oligonucleotides, 10.1021/mp4002624
  33. Secret Emilie, Smith Kevin, Dubljevic Valentina, Moore Eli, Macardle Peter, Delalat Bahman, Rogers Mary-Louise, Johns Terrance G., Durand Jean-Olivier, Cunin Frédérique, Voelcker Nicolas H., Antibody-Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs, 10.1002/adhm.201200335
  34. Santos Hélder A., Riikonen Joakim, Salonen Jarno, Mäkilä Ermei, Heikkilä Teemu, Laaksonen Timo, Peltonen Leena, Lehto Vesa-Pekka, Hirvonen Jouni, In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size, 10.1016/j.actbio.2009.12.043
  35. Shrestha Neha, Shahbazi Mohammad-Ali, Araújo Francisca, Zhang Hongbo, Mäkilä Ermei M., Kauppila Jussi, Sarmento Bruno, Salonen Jarno J., Hirvonen Jouni T., Santos Hélder A., Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers, 10.1016/j.biomaterials.2014.04.104
  36. Shahbazi Mohammad-Ali, Almeida Patrick V., Mäkilä Ermei M., Kaasalainen Martti H., Salonen Jarno J., Hirvonen Jouni T., Santos Hélder A., Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering, 10.1016/j.biomaterials.2014.05.020
  37. Jalkanen Tero, Mäkilä Ermei, Sakka Tetsuo, Salonen Jarno, Ogata Yukio H, Thermally promoted addition of undecylenic acid on thermally hydrocarbonized porous silicon optical reflectors, 10.1186/1556-276x-7-311
  38. Occhipinti Emanuela, Verderio Paolo, Natalello Antonino, Galbiati Elisabetta, Colombo Miriam, Mazzucchelli Serena, Salvadè Agnese, Tortora Paolo, Doglia Silvia Maria, Prosperi Davide, Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles, 10.1039/c0nr00436g
  39. Danhier Fabienne, Feron Olivier, Préat Véronique, To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery, 10.1016/j.jconrel.2010.08.027
  40. Sasidharan Sisini, Jayasree Aswathy, Fazal Sajid, Koyakutty Manzoor, Nair Shantikumar V., Menon Deepthy, Ambient temperature synthesis of citrate stabilized and biofunctionalized, fluorescent calcium fluoridenanocrystals for targeted labeling of cancer cells, 10.1039/c2bm00127f
  41. KONG Jilie, YU Shaoning, Fourier Transform Infrared Spectroscopic Analysis of Protein Secondary Structures, 10.1111/j.1745-7270.2007.00320.x
  42. Kwon Il Keun, Lee Sang Cheon, Han Bumsoo, Park Kinam, Analysis on the current status of targeted drug delivery to tumors, 10.1016/j.jconrel.2012.07.010
  43. Shen Jianan, Sun Huiping, Meng Qingshuo, Yin Qi, Zhang Zhiwen, Yu Haijun, Li Yaping, Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA, 10.1021/mp4006408
  44. Seidel Ursula J. E., Schlegel Patrick, Lang Peter, Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies, 10.3389/fimmu.2013.00076
  45. Weiner Louis M, Dhodapkar Madhav V, Ferrone Soldano, Monoclonal antibodies for cancer immunotherapy, 10.1016/s0140-6736(09)60251-8
  46. Chowdhury Ferdousi, Lode Holger N., Cragg Mark S., Glennie Martin J., Gray Juliet C., Development of immunomonitoring of antibody-dependent cellular cytotoxicity against neuroblastoma cells using whole blood, 10.1007/s00262-014-1534-y
  47. Iannello Alexandre, Ahmad Ali, Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies, 10.1007/s10555-005-6192-2
  48. van Sorge N.M., van der Pol W-L., van de Winkel J.G.J., FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy, 10.1034/j.1399-0039.2003.00037.x
  49. Smith K., Interleukin-2: inception, impact, and implications, 10.1126/science.3131876
  50. Strome S. E., Sausville E. A., Mann D., A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects, 10.1634/theoncologist.12-9-1084
  51. Kawaguchi Yoshihiko, Kono Koji, Mimura Kousaku, Sugai Hidemitsu, Akaike Hidenori, Fujii Hideki, Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma : Cetuximab for Esophageal Squamous Cell Carcinoma, 10.1002/ijc.22370
  52. El-Dakdouki Mohammad H., Puré Ellen, Huang Xuefei, Development of drug loaded nanoparticles for tumor targeting. Part 1: synthesis, characterization, and biological evaluation in 2D cell cultures, 10.1039/c3nr33777d